Bell Asset Management Ltd Sells 2,606 Shares of Synopsys, Inc. $SNPS

Bell Asset Management Ltd lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 21.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,608 shares of the semiconductor company’s stock after selling 2,606 shares during the period. Bell Asset Management Ltd’s holdings in Synopsys were worth $4,926,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Nuveen LLC purchased a new stake in Synopsys in the first quarter worth $341,480,000. Generation Investment Management LLP bought a new position in shares of Synopsys during the 1st quarter worth $240,491,000. Vanguard Group Inc. grew its stake in shares of Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after acquiring an additional 346,994 shares during the period. Aspex Management HK Ltd increased its holdings in Synopsys by 106.0% in the 2nd quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after acquiring an additional 332,364 shares during the last quarter. Finally, Alliancebernstein L.P. increased its holdings in Synopsys by 22.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after acquiring an additional 313,218 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $409.68 on Thursday. The company has a 50 day moving average of $443.27 and a 200 day moving average of $508.76. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market cap of $76.10 billion, a P/E ratio of 32.16, a P/E/G ratio of 5.02 and a beta of 1.10. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same period in the previous year, the business earned $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insiders Place Their Bets

In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. This represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,655 shares of the firm’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the sale, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Corporate insiders own 0.62% of the company’s stock.

Analyst Ratings Changes

SNPS has been the subject of a number of research reports. KeyCorp cut their target price on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Stifel Nicolaus lowered their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Citigroup started coverage on shares of Synopsys in a report on Monday. They issued a “buy” rating and a $580.00 price objective for the company. Piper Sandler reduced their price objective on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research note on Wednesday, September 10th. Finally, Rosenblatt Securities reissued a “neutral” rating and set a $605.00 target price (down previously from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $556.33.

Check Out Our Latest Stock Analysis on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.